Continuing Education

We offer a robust selection of courses, lectures, and workshops led by expert faculty and industry leaders. Whether you’re looking to deepen your clinical expertise, explore emerging technologies, or meet licensure requirements, you’ll find opportunities that are both relevant and engaging.

NECO’s CE programming is flexible, with in-person events, live webinars, and on-demand courses that fit your schedule. Each session is crafted to deliver actionable insights you can bring directly to your practice, ensuring that your skills and knowledge remain current in an ever-changing field.

Join a community of lifelong learners dedicated to advancing the profession of optometry. At NECO, we’re here to support your journey—wherever it takes you next. Contact us for more information.

Relief Without Opioids: Screening, Counseling, and Non-Opioid Pain Care

Tuesday, December 9, 2025
7:00–9:00PM

$50 | Live Webinar | 2 hours of CE
(COPE accreditation pending)

Instructor:
David Shein, MD

This two-hour webinar prepares optometrists to deliver safe, effective pain care without opioids. Participants will learn to identify patients at risk for Opioid misuse, counsel on side effects, safe use, storage, and disposal, and direct treatment toward evidence-based non-opioid options for common ocular pain (abrasions, inflammatory conditions, post-procedure discomfort). The session includes overdose prevention fundamentals, including when and how to recommend naloxone and how patients can access it. The course closes with documentation language and workflows that align with Massachusetts training requirements.

Glaucoma Grand Rounds

Sunday, December 14, 2025
9:00AM–12:00PM

$75 | Live Webinar | 3 hours of CE
(COPE accreditation pending)

Instructors:
Anne Bertolet, OD
Bob Dunphy, OD
Jake Hillard, OD
Joey Kane, OD
Douglas Rett, OD 

Glaucoma Grand Rounds is a three-hour, case-based continuing education course designed to sharpen clinical decision making in the diagnosis, treatment, and long term management of glaucoma. Through a series of real world cases ranging from early, suspicious findings to complex, advanced disease, participants will revisit core principles, review evolving evidence, and apply new knowledge to nuanced clinical scenarios. Emphasis will be placed on interpreting tests, risk stratification, treatment escalation and de escalation, and coordinating care across providers to optimize outcomes. The program will conclude with an interactive panel discussion featuring all five speakers, allowing attendees to compare management approaches, ask questions, and deepen their critical thinking around challenging glaucoma cases.  

Multidisciplinary Strategies to Ensure Equity Across the Continuum of Diabetic Eye Care

Free | Self-Paced | 1 credit

Instructors:
Joseph M. Coney, MD, FASRS, FACS
Steven Ferrucci, OD, FAAO
Veeral Sheth, MD, MBA

Eye care specialists examine the causes and potential solutions to barriers that create inequities in diabetic eye care, from screening to treatment. Learners will engage with a robust discussion of strategies to optimize the care of racial/ethnic minorities with, or at risk for, diabetic eye disease, including recent data addressing the unmet needs of these groups in clinical trials.

This activity is provided by Paradigm Medical Communications, LLC, in collaboration with NECO and supported by an educational grant from Genentech, a member of the Roche Group.

Unique, New Strategies for the Pharmaologic Treatment of Dry Eye Disease: Focus on Neuromodulation

Free | 45 Minutes | .75 credit

Instructors:
David Wirta, OD

Selina Riann McGee, OD, FAAO

Increased understanding of the neurobiology of dry eye disease (DED) has led to a greater appreciation of its significant and potentially serious impact on patients’ vision and quality of life. Emerging treatments for DED go beyond mere symptom management to target its neurobiology. Join an expert panel consisting of an ophthalmologist and an optometrist to discuss the burden and causes of DED, the role of the lacrimal functional unit (LFU) in DED pathophysiology, and the rationale for targeted neuromodulation. The panel will also explore the symptoms of DED and the new pharmacologic agents that target the LFU, along with clinical evidence supporting their use. The program will also include a video vignette of a patient with DED to highlight the challenges and realities of living with DED.

Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the New England College of Optometry (NECO).

Addressing Real-World Challenges in Neovascular Eye Diseases with New Treatment Regimens

Free | Self-Paced | .75 credit

Instructors:
Rishi P. Singh, MD, FASRS
Chair, Mass Eye and Ear, MGB

Peter A. Campochiaro, MD
Eccles Prof. Ophthalmology & Neuroscience
The Wilmer Institute, Johns Hopkins University SOM

Intravitreally administered anti-vascular endothelial growth factor (anti-VEGF) therapies have transformed the treatment landscape for neovascular age-related macular degeneration (nAMD), and diabetic macular edema (DME).  However, clinicians need ongoing education on these emerging therapies and the real-world patient experiences with them.

An expert panel of two ophthalmologists will explore how anti-angiogenesis agents can help reduce treatment burden faced by patients while achieving optimal vision outcomes. This educational session will help clinicians understand the magnitude of the burden of retinal diseases and to emphasize the urgency of early diagnosis and evidence-based treatments to reduce frequent visits and improve patient outcomes.

Jointly provided by Partners for Advancing Clinical Education (PACE) and PlatformQ Health Education, LLC, in collaboration with the New England College of Optometry (NECO).

VA Boston Resident CE Lecture Series

Our VA Healthcare System lectures are presented by VA/NECO optometry residents. This is a partnership between NECO, VA Boston Healthcare System, and other VA medical centers.

Upcoming Resident CE Presentations

All lectures are on Fridays from 2:00–4:00PM (one hour each with a short break in between). Interested parties may contact joseph.kane@va.gov to receive future invitations.

 

11/28/2025
NO ROUNDS    

Holiday (Day After Thanksgiving)

 

12/05/2025
Michelle Curtis, OD (WX): LGN Visual Pathway Lesions

Emily Coan, OD (JP): Visual Complications (Bowtie Atrophy and Bitemporal VF loss) from an Adamantinomas Craniopharyngioma

 

12/12/2025       
Madison Robitaille, OD (LO): AZOOR

Matthew Pham, OD (JP – LV/POLYTRAUMA): Beyond the Occipital Lobe

 

12/19/2025    
Serena Wang, OD (BR): Belantamab Mafodotin

Opioid Use and Toxicity: Medical Considerations for the Practicing Optometrist

$25 | Self-Paced | 1 credit

Instructor:
David Shein, MD

This comprehensive course covers essential aspects of opioid pharmacology, clinical considerations, and patient management. Topics include the pharmacological properties of opioids, potential drug effects and adverse reactions, and best practices for pain management. Participants will gain insights into recognizing and managing Opioid Use Disorder (OUD), understanding clinical considerations, and identifying and responding to opioid toxicity. Emphasis is placed on both identification and acute management strategies to ensure a well-rounded understanding of opioid use in clinical settings.

Finding Keratoconus Before It Finds You

$200 | Self-Paced | 8 credits

Instructors:
Jason Brenner, MD
Clark Chang, OD, MSc, FAAO, FSLS
Gloria Chiu OD, FAAO, FSLS
Eric Conley OD, FAAO
Anita Gulmiri, OD, FAAO, FSLS
Jennifer Liao OD, FAAO, FSLS
Brittney Mazza, OD
Samir Melki, MD, PhD
Vivian Yao, OD

This CE series will review best practices for treating keratoconus, the most commonly encountered form of irregular cornea. Over the last decade, treatment options have evolved to include early detection and the use of corneal collagen crosslinking and scleral lenses. Experts in the field will share their management experiences and present new research findings in the keratoconus arena.

Glaucoma Examination & Diagnostic Approach

$100 | Self-Paced | 4 credits

Instructors:
Emily Carell, OD, FAAO and Rachel C. Druckenbrod, OD FAAO

This course is a comprehensive guide to glaucoma diagnosis and management. Participants will explore key components of the glaucoma exam, including IOP measurement, CCT, anterior segment, and optic nerve assessment, alongside essential ancillary testing like visual fields and OCT. The course covers how to synthesize diagnostic data, illustrated through case examples, and reviews current treatment approaches to improve patient outcomes.

Fundamentals of OCT

$150 | Self-Paced |  6 credits

Instructors: 
George Asimellis, PhD, MBA
Elena Biffi, OD, MSc, FAAO
Timothy Bossie, OD, FAAO
Joseph Kane, OD, FAAO
Jennifer Reilly, OD, MS, FAAO

OCT has become a gold standard in the delivery of eye care to diagnose and manage posterior segment diseases of the optic nerve and retina, in particular, glaucoma and macular diseases. This six-part course provides a continual curriculum of OCT technologies, from basic physical science concepts to image interpretation, analysis, and management of pathology. 

Amblyopia Treatment: How Clinical Trials are Redefining Patient Care

$25 | Self-Paced | 1 credit

Instructor:
Susan Cotter, OD, MS, FAAO

This course offers an evidence-based update on amblyopia management tailored for the busy clinician. Guided by findings from the PEDIG amblyopia treatment studies, it highlights the evolution of treatment guidelines and provides clinical insights into optical correction, patching, atropine penalization, and the latest advancements in binocular therapy. Practical strategies for managing patients with unilateral and bilateral amblyopia across different ages and severities are discussed, equipping clinicians with up-to-date solutions for effective care.